Crescentis Capital Q1 FY27: Sales up 121%, NP up 133%

What changed this quarter

Crescentis Capital reported a sharp year-on-year rise in quarterly sales and profit for the quarter ended June 2026. Sales rose 121.01% to ₹10.94 crore, compared with ₹4.95 crore in the quarter ended June 2025. Net profit rose 133.43% to ₹7.82 crore, up from ₹3.35 crore a year earlier. The update matters because the company is also moving through a busy corporate calendar in August, including a board meeting to consider Q1 unaudited results and its annual general meeting.

Q1 FY27 performance at a glance

The quarter ended June 2026 showed a high operating margin and strong profit before tax on the reported numbers. Operating profit margin (OPM) was reported at 89.40%, compared with 83.23% in the year-ago quarter. Profit before depreciation and tax (PBDT) stood at ₹9.70 crore versus ₹4.11 crore. Profit before tax (PBT) came in at ₹9.63 crore versus ₹4.11 crore.

Key quarterly numbers (Q1)

Profitability and operating profile

With OPM near 90%, the quarter reflects a high-margin profile on reported operating metrics. The company also reported a strong gap between sales and profits, with PBDT of ₹9.70 crore against sales of ₹10.94 crore. Net profit of ₹7.82 crore indicates a substantial portion of operating earnings flowing through to the bottom line for the quarter. The disclosure provides headline performance numbers but does not detail segment-level drivers in the provided text.

Board meeting on August 13, 2026: what is on the agenda

Crescentis Capital Limited (CIN: L65921TS1993PLC188494) informed BSE Limited that a meeting of its Board of Directors is scheduled for Thursday, 13th August, 2026. The key agenda is to consider, approve, and take on record the unaudited financial results for the 1st quarter ended 30th June, 2026, along with the limited review report. This scheduled meeting is the formal step for taking Q1 numbers on record under the company’s disclosure obligations.

Trading window closure details

On trading restrictions, the company referred to its earlier intimation dated 26th June, 2026. The trading window for dealing in the company’s securities has remained closed with effect from 1st July, 2026. It is scheduled to re-open 48 hours after the declaration of the above financial results. Such windows are typically used to manage unpublished price sensitive information periods around results.

AGM schedule and shareholder dates

The company’s 33rd Annual General Meeting is scheduled for Wednesday, August 26, 2026 at 12:00 noon (IST) through video conferencing or other audio visual means. The cut-off date for shareholders is Friday, August 21, 2026. Remote e-voting is scheduled from August 22, 2026 (09:00 AM) to August 25, 2026 (05:00 PM). The notice and annual report were sent electronically to members on July 30, 2026.

Key AGM and e-voting dates

FY26 context: improved but still a net loss

For FY 2025-26, Crescentis Capital reported total income of ₹1.55 crore, compared with negative ₹3.02 crore in FY25. It reported interest income of ₹3.25 crore from lending operations that commenced in June 2025. Investment income was reported at negative ₹1.77 crore, including a realised gain of ₹2.69 crore, an unrealised loss of ₹4.85 crore, and dividend income of ₹0.39 crore. Total expenses were ₹4.75 crore, including finance costs of ₹0.28 crore and impairment on loan assets of ₹0.32 crore.

The company reported a loss before tax of ₹3.20 crore in FY26, improved from ₹5.82 crore in FY25. Net loss narrowed to ₹2.53 crore from ₹5.42 crore in FY25. Total comprehensive loss was ₹2.50 crore versus ₹5.43 crore in FY25. The FY numbers show improvement but also highlight that quarterly profitability can differ materially from full-year outcomes.

Balance sheet snapshot as of March 31, 2026

As of March 31, 2026, total assets were reported at ₹91.25 crore. Net loans were ₹45.95 crore, against gross loans of ₹46.43 crore. Net worth was reported at ₹76.04 crore. Equity share capital stood at ₹17.01 crore, comprising 17,013,549 shares of ₹10 each. These figures provide context for the company’s lending and investment activities referenced in the FY26 highlights.

Corporate actions and fundraising: rights issue proposal

In a separate disclosure about a board meeting outcome dated May 29, 2026, the company said its board approved the FY26 audited financials. It reported a net loss of ₹2.53 crore for the year and a net loss of ₹7.35 crore for Q4 FY26. The board also approved raising up to ₹80 crore through a rights issue of fully paid-up equity shares. The company had also indicated it would explore multiple fundraising modes, including rights issue and other permissible methods, subject to approvals.

Share and listing details reported

The company’s shares are listed on BSE Limited under Scrip Code 511571 (ISIN: INE754C01010). A reported data point in the provided text puts the share price at ₹124.8 as of 20 June, 2026. Another reported price point shows ₹118.9 on June 15, 2026. The provided text also states an EPS (TTM) of -1.57.

What investors typically track next

The next immediate event is the August 13, 2026 board meeting to take Q1 unaudited results on record along with the limited review report. Investors also track the reopening of the trading window, which is set for 48 hours after the declaration of results. On the governance calendar, the AGM on August 26, 2026 and the voting window between August 22 and August 25, 2026 are key dates. Separately, the rights issue proposal up to ₹80 crore remains a significant corporate action to monitor based on subsequent announcements.

Conclusion

Crescentis Capital’s quarter ended June 2026 showed strong year-on-year growth in sales and net profit on the reported numbers. The company has scheduled an August 13, 2026 board meeting to approve and take on record Q1 unaudited results, with the trading window to re-open 48 hours after the declaration. The 33rd AGM on August 26, 2026 and the previously approved rights issue plan up to ₹80 crore are the next confirmed milestones on the company’s calendar.